IBC Life Sciences

IBC's Well Characterized Biologicals conference is the leading industry conference to provide multiple, practical case studies of the challenges, strategies and technologies involved in protein characterization.

Conference Highlights

• Hear lessons learned from numerous speakers about process changes that worked or didn't work
• Benchmark your own practices against industry leading companies
• Find out how others are tackling common issues related to analytical testing methods, new technologies and regulatory requirements
• Learn how to navigate the ever-changing regulatory landscape as characterization techniques become more advanced and protein products become more complex
• Share successful strategies and best practices with fellow scientists and regulatory officials to help you optimize your product and process knowledge

Join us in 2010 and find out why IBC's Well Characterized Biologicals conference has been one of the bioprocess industry's most respected, must-attend events for over 13 years.

Scientific Advisory Committee

• Reed Harris, Director, Analytical Development, Genentech, Inc.
• John P. Hennessey, Jr., Ph.D., Vice President, Research & Development, NovaDigm Therapeutics, Inc.
• Alan V. Klotz, Ph.D., Research Advisor/CM&C Leader, Elanco Biosciences
• Joseph Kutza, Ph.D., Associate Director, CMC Regulatory Affairs, MedImmune
• Ned Mozier, Ph.D., Director, Analytical Sciences, Global Biologics Research and Development, Pfizer, Inc.
• Michael G. Mulkerrin, Ph.D., Vice President, Process Development, OncoMed Pharmaceuticals
• Nadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group
• Richard Strong, Ph.D. Senior Scientist, Analytical Development, Biogen Idec

Contacts:

Speaking Opportunities:
Michael Keenan, Tel: 949-276-2634
E-mail: mkeenan@ibcusa.com

Sponsorship/Exhibiting:
Jennifer McElligott, Tel: 508-614-1672
E-mail: jmcelligott@ibcusa.com

Media Partnerships:
Steve Garofalo, Tel: 508-614-1235
E-mail: sgarofalo@ibcusa.com